secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2026-04-14T23:59:59+00:00
Accession:  0001919246-26-000060
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Scott Plesha to attend Piper Sandler Spring Biopharma Symposium on April 16, 2026
--------------------------------------------------------------------------------

- CEO will hold one-on-one investor meetings at conference in Boston.
- Corporate presentation made available on company website but contains no new material disclosures.
- No financial results, pipeline updates, or material events announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000191924626000060/0001919246-26-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000191924626000060/pths-20260414.htm
  HTML page:      https://secwatch.observer/filing/0001919246-26-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer